105 related articles for article (PubMed ID: 7414500)
1. Endocrine outcome after transsphenoidal adenomectomy for prolactinoma: prolactin levels and tumor size as predicting factors.
Aubourg PR; Derome PJ; Peillon F; Jedynak CP; Visot A; Le Gentil P; Balagura S; Guiot G
Surg Neurol; 1980 Aug; 14(2):141-3. PubMed ID: 7414500
[TBL] [Abstract][Full Text] [Related]
2. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma.
Serri O; Rasio E; Beauregard H; Hardy J; Somma M
N Engl J Med; 1983 Aug; 309(5):280-3. PubMed ID: 6866052
[TBL] [Abstract][Full Text] [Related]
3. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
[TBL] [Abstract][Full Text] [Related]
4. [Hyperprolactinemia in patients with non-functioning adenoma: analysis of 85 patients treated by transsphenoidal operation].
Saitoh Y; Mori S; Arita N; Hayakawa T; Mogami H; Oku Y; Onishi T; Uozumi T
No Shinkei Geka; 1987 Nov; 15(11):1175-9. PubMed ID: 3437926
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.
Amar AP; Couldwell WT; Chen JC; Weiss MH
J Neurosurg; 2002 Aug; 97(2):307-14. PubMed ID: 12186458
[TBL] [Abstract][Full Text] [Related]
6. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
[TBL] [Abstract][Full Text] [Related]
7. [Endocrine prognosis of PRL-secreting pituitary adenomas. In 90 female cases (author's transl)].
Aubourg P; Derome DJ; Peillon F; Jedynak CP; Visot A; Legentil P; Guiot G
Ann Endocrinol (Paris); 1980; 41(1):57-8. PubMed ID: 7396396
[TBL] [Abstract][Full Text] [Related]
8. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy.
Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J
J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986
[TBL] [Abstract][Full Text] [Related]
10. [Transsphenoidal approach to prolactinomas].
López-Arbolay O; Morales-Sabina O; González-González JL; Valdés-Lorenzo N
Neurocirugia (Astur); 2006 Jun; 17(3):226-31. PubMed ID: 16855780
[TBL] [Abstract][Full Text] [Related]
11. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
12. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
[TBL] [Abstract][Full Text] [Related]
13. [Surgery of pituitary adenoma].
Derome PJ; Visot A
Rev Prat; 1996 Jun; 46(12):1515-9. PubMed ID: 8881167
[TBL] [Abstract][Full Text] [Related]
14. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
[TBL] [Abstract][Full Text] [Related]
15. Transsphenoidal surgery for prolactin-secreting pituitary tumors: a study of 28 cases and review of the literature.
Smallridge RC; Martins AN
South Med J; 1982 Aug; 75(8):963-8. PubMed ID: 7202255
[TBL] [Abstract][Full Text] [Related]
16. Infertility in patients with hyperprolactinemia from a pituitary adenoma. Effect of transsphenoidal pituitary adenectomy.
Dolman LI; Roberts TS; Poulson M; Tyler FH
Arch Intern Med; 1977 Sep; 137(9):1161-4. PubMed ID: 901084
[TBL] [Abstract][Full Text] [Related]
17. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
18. Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
[TBL] [Abstract][Full Text] [Related]
19. Prolactinomas: surgical therapy, indications and results.
Rawe SE; Williamson HO; Levine JH; Phansey SA; Hungerford D; Adkins WY
Surg Neurol; 1980 Sep; 14(3):161-7. PubMed ID: 7434180
[TBL] [Abstract][Full Text] [Related]
20. [Amenorrhoea and hyperprolactinaemia (author's transl)].
Tscherne G
Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 543141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
